Chemotherapy-induced peripheral neuropathy

TJ Brown, R Sedhom, A Gupta - JAMA oncology, 2019 - jamanetwork.com
I Have CIPN—What Now? One should avoid injury by paying attention to home safety, such
as by using handrails on stairs to prevent falls and potholders in the kitchen to avoid burns …

Recommendations for prevention and management of chemotherapy-induced peripheral neuropathy

BA Derman, AM Davis - JAMA, 2021 - jamanetwork.com
Summary of the Clinical Problem Chemotherapy-induced peripheral neuropathy (CIPN) is a
particularly challenging pain syndrome that typically occurs in patients with cancer who have …

The national cancer institute clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy

SG Dorsey, IR Kleckner, D Barton… - JNCI: Journal of the …, 2019 - academic.oup.com
Although recent scientific advances have improved our understanding of basic biological
mechanisms underlying chemotherapy-induced peripheral neuropathy (CIPN), few …

[引用][C] Grading of chemotherapy-induced peripheral neuropathy

TJ Postma, JJ Heimans - Annals of Oncology, 2000 - Elsevier
Peripheral neuropathy can be defined as a derangement in structure and function of
peripheral motor, sensory, and autonomic neurons [1], causing peripheral neuropathic …

Chemotherapy-induced peripheral neuropathy and rehabilitation: A review

S Zhang - Seminars in oncology, 2021 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication after
chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves in …

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise

KY Wonders, BS Reigle, DG Drury - Oncology Reviews, 2010 - Springer
Chemotherapy-induced peripheral neuropathy (CIPN) is a common, dose-limiting effect of
cancer therapy that often has negative implications on a patient's quality of life. The pain …

Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data

JS Gewandter, AS Kleckner, JH Marshall… - Supportive Care in …, 2020 - Springer
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication
of many chemotherapies. We investigated the feasibility of using health plan claims and …

National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

N Majithia, SM Temkin, KJ Ruddy, AS Beutler… - Supportive Care in …, 2016 - Springer
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and
debilitating complications of cancer treatment. Due to a lack of effective management …

Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design

DC St. Germain, AM O'Mara, JL Robinson, AD Torres… - Cancer, 2020 - Wiley Online Library
Background To the authors' knowledge, the empiric identification of agents and interventions
to mitigate chemotherapy‐induced peripheral neuropathy (CIPN) has resulted in only 1 …

Chemotherapy-induced peripheral neuropathy in cancer survivors

BA Boland, MSN Victoria Sherry - Oncology, 2010 - search.proquest.com
Upon reviewing JB's history for risks of peripheral neuropathy, it is important to consider her
cancer treatment and health history. This patient completed her last course of chemotherapy …